BioSpace News Archive

Novocure (NASDAQ: NVCR) today reported financial results for the quarter ended March 31, 2024.

Novocure (NASDAQ: NVCR) announced today that it has entered into a new five-year up to $400 million committed senior secured credit facility with funds managed by Pharmakon Advisors, LP.

Mind Medicine announced today that it plans to host a conference call on Wednesday, May 8, 2024, at 4:30 p.m. ET to provide a corporate update and review the Company’s results for the first quarter ended March 31, 2024.

Chemomab Therapeutics Ltd., a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, announced that Chief Executive Officer Dr. Adi Mor will deliver a corporate presentation at the Aegis Virtual Conference on May 7, 2024 at 9:00 am ET. Dr. Mor’s presentation will be webcast live.

Shattuck Labs, Inc. reported financial results for the quarter ended March 31, 2024 and provided recent business highlights.

CytoSorbents Corporation announced that it will host a virtual Key Opinion Leader and Analyst-Investor Day on Monday, May 6, 2024 from 11:30 AM to 1:30 PM ET.

Pluri Inc., a leading biotechnology company that transforms cells into solutions, launched its placental allogeneic MAIT cell platform for immunotherapy treatment for solid tumors – a significant medical need which currently lacks effective treatments.

Prelude Corporation, a leader in precision diagnostics for early-stage breast cancer, announced the appointment of Dr. Pat Whitworth as its new Chief Medical Officer.

Sotera Health Company, a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, announced financial results for the three months ended March 31, 2024.

Ginkgo Bioworks Holdings, Inc. announced that it plans to host a presentation and Q&A session reviewing business performance for the first quarter ended March 31, 2024, on Thursday, May 9, 2024, beginning at 5:30 p.m. ET.